BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22161215)

  • 1. Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.
    Oishi Y; Watanabe Y; Yoshida Y; Sato Y; Hiraishi T; Oikawa R; Maehata T; Suzuki H; Toyota M; Niwa H; Suzuki M; Itoh F
    Tumour Biol; 2012 Apr; 33(2):383-93. PubMed ID: 22161215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival.
    Balgkouranidou I; Karayiannakis A; Matthaios D; Bolanaki H; Tripsianis G; Tentes AA; Lianidou E; Chatzaki E; Fiska A; Lambropoulou M; Kolios G; Kakolyris S
    Clin Chem Lab Med; 2013 Jul; 51(7):1505-10. PubMed ID: 23403728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients.
    Karamitrousis EI; Balgkouranidou I; Xenidis N; Amarantidis K; Biziota E; Koukaki T; Trypsianis G; Karayiannakis A; Bolanaki H; Kolios G; Lianidou E; Kakolyris S
    Technol Cancer Res Treat; 2021; 20():1533033820973279. PubMed ID: 33928818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes.
    Watanabe Y; Kim HS; Castoro RJ; Chung W; Estecio MR; Kondo K; Guo Y; Ahmed SS; Toyota M; Itoh F; Suk KT; Cho MY; Shen L; Jelinek J; Issa JP
    Gastroenterology; 2009 Jun; 136(7):2149-58. PubMed ID: 19375421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
    Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
    Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
    Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T
    Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
    Yanagawa N; Tamura G; Honda T; Endoh M; Nishizuka S; Motoyama T
    Clin Cancer Res; 2004 Apr; 10(7):2447-51. PubMed ID: 15073123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
    Akino K; Toyota M; Suzuki H; Imai T; Maruyama R; Kusano M; Nishikawa N; Watanabe Y; Sasaki Y; Abe T; Yamamoto E; Tarasawa I; Sonoda T; Mori M; Imai K; Shinomura Y; Tokino T
    Cancer Sci; 2007 Jan; 98(1):88-95. PubMed ID: 17083569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
    Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
    Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
    Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
    Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of somatostatin in gastric cancer.
    Jackson K; Soutto M; Peng D; Hu T; Marshal D; El-Rifai W
    Dig Dis Sci; 2011 Jan; 56(1):125-30. PubMed ID: 20927589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
    Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
    J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.
    Jee CD; Kim MA; Jung EJ; Kim J; Kim WH
    Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of CXCL12 by DNA hypermethylation and its involvement in gastric cancer metastatic progression.
    Zhi Y; Chen J; Zhang S; Chang X; Ma J; Dai D
    Dig Dis Sci; 2012 Mar; 57(3):650-9. PubMed ID: 21960286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
    Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
    Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.